Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City

• Published in: Nature (London) Vol. 590; no. 7844; pp. 146 - 150
• Main Authors: Stadlbauer, Daniel, Tan, Jessica, Jiang, Kaijun, Hernandez, Matthew M., Fabre, Shelcie, Amanat, Fatima, Teo, Catherine, Arunkumar, Guha Asthagiri, McMahon, Meagan, Capuano, Christina, Twyman, Kathryn, Jhang, Jeffrey, Nowak, Michael D., Simon, Viviana, Sordillo, Emilia Mia, van Bakel, Harm, Krammer, Florian
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 04.02.2021; Nature Publishing Group
• Subjects: 631/250/2152/2153/1291; 631/326/596/4130; 82; 82/1; Adolescent; Adult; Ambulatory Care - statistics & numerical data; Antibodies; Antibodies, Viral - blood; Antibodies, Viral - immunology; Child; Child, Preschool; Coronaviruses; COVID-19; COVID-19 - diagnosis; COVID-19 - epidemiology; COVID-19 - immunology; COVID-19 - virology; COVID-19 Serological Testing - statistics & numerical data; Cross-Sectional Studies; Enzymes; Epidemics; Epidemiological Monitoring; Fatalities; Female; Humanities and Social Sciences; Humans; Incidence; Infant; Infant, Newborn; Infections; Male; Metropolitan areas; Middle Aged; multidisciplinary; New York City - epidemiology; Pandemics; Population; Proteins; SARS-CoV-2 - immunology; Science; Science (multidisciplinary); Seroconversion; Severe acute respiratory syndrome coronavirus 2; Spike Glycoprotein, Coronavirus - immunology; Time Factors; Urban Population - statistics & numerical data; Viral diseases; Young Adult; New York City; United States > US; New York City New York

In late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first detected in China and has since caused a pandemic of coronavirus disease 2019 (COVID-19). The first case of COVID-19 in New York City was officially confirmed on 1 March 2020 followed by a severe local epidemic 1 ....